These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 9709031
1. Leishmania mexicana: extracellular proton concentration is a key regulator of cysteine proteinase CPb expression. Ke G, Mauël J, Rivier D. Exp Parasitol; 1998 Sep; 90(1):58-64. PubMed ID: 9709031 [Abstract] [Full Text] [Related]
3. Growth phase and medium ph modulate the expression of proteinase activities and the development of megasomes in axenically cultivated Leishmania (Leishmania) amazonensis amastigote-like organisms. Pral EM, da Moitinho ML, Balanco JM, Teixeira VR, Milder RV, Alfieri SC. J Parasitol; 2003 Feb; 89(1):35-43. PubMed ID: 12659300 [Abstract] [Full Text] [Related]
5. Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis. Zadeh-Vakili A, Taheri T, Taslimi Y, Doustdari F, Salmanian AH, Rafati S. Vaccine; 2004 May 07; 22(15-16):1930-40. PubMed ID: 15121305 [Abstract] [Full Text] [Related]
7. Comparative analysis of megasomes in members of the Leishmania mexicana complex. Ueda-Nakamura T, Attias M, de Souza W. Res Microbiol; 2007 Jun 07; 158(5):456-62. PubMed ID: 17524623 [Abstract] [Full Text] [Related]
12. Cysteine peptidases in Herpetomonas samuelpessoai are modulated by temperature and dimethylsulfoxide-triggered differentiation. Pereira FM, Elias CG, d'Avila-Levy CM, Branquinha MH, Santos AL. Parasitology; 2009 Jan 07; 136(1):45-54. PubMed ID: 19126269 [Abstract] [Full Text] [Related]
14. In vitro maintenance of Leishmania amastigotes directly from lesions: advantages and limitations. Hodgkinson VH, Soong L. J Parasitol; 1997 Oct 07; 83(5):953-6. PubMed ID: 9379307 [Abstract] [Full Text] [Related]
15. Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms. Hodgkinson VH, Soong L, Duboise SM, McMahon-Pratt D. Exp Parasitol; 1996 Jun 07; 83(1):94-105. PubMed ID: 8654556 [Abstract] [Full Text] [Related]
16. Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models. Saravia NG, Escorcia B, Osorio Y, Valderrama L, Brooks D, Arteaga L, Coombs G, Mottram J, Travi BL. Vaccine; 2006 May 08; 24(19):4247-59. PubMed ID: 16216395 [Abstract] [Full Text] [Related]
17. Uptake of Z-Tyr[125I]-AlaCHN2, an irreversible cysteine proteinase inhibitor, by lesion amastigotes, axenic amastigotes and promastigotes of Leishmania mexicana. Pral EM, Alfieri SC. Braz J Med Biol Res; 1996 Aug 08; 29(8):987-94. PubMed ID: 9181079 [Abstract] [Full Text] [Related]
18. Interaction of different Leishmania mexicana morphotypes with plasminogen. Calcagno M, Avilan L, Colasante C, Berrueta L, Salmen S. Parasitol Res; 2002 Nov 08; 88(11):972-8. PubMed ID: 12375162 [Abstract] [Full Text] [Related]